All Stories

  1. Acetazolamide effect on nocturnal oxygenation, breathing and sleep in healthy individuals older than 40 years. RCT
  2. Acetazolamide for Preventing Acute Mountain Sickness in Healthy Older than 40 years. RCT
  3. Markers of cardiovascular risk and their reversibility with acute oxygen therapy in Kyrgyz highlanders with high altitude pulmonary hypertension
  4. Extravascular lung water and cardiac function assessed by echocardiography in healthy lowlanders during repeated very high-altitude exposure
  5. Nocturnal cerebral tissue oxygenation in lowlanders with chronic obstructive pulmonary disease travelling to an altitude of 2,590 m: Data from a randomised trial
  6. Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen Therapy
  7. Effect of High-Flow Oxygen on Exercise Performance in COPD Patients. Randomized Trial
  8. Pulmonary haemodynamic response to exercise in highlanders versus lowlanders
  9. ECG changes at rest and during exercise in lowlanders with COPD travelling to 3100 m
  10. Effect of Normobaric Hypoxia on Exercise Performance in Pulmonary Hypertension
  11. Validation of a Portable Blood Gas Analyzer for Use in Challenging Field Conditions at High Altitude
  12. Health Preference Measures in Patients with Obstructive Sleep Apnea Syndrome Undergoing Continuous Positive Airway Pressure Therapy: Data from a Randomized Trial
  13. Right Atrial Pressure During Exercise Predicts Survival in Patients With Pulmonary Hypertension
  14. Altitude Travel in Patients With Pulmonary Hypertension: Randomized Pilot-Trial Evaluating Nocturnal Oxygen Therapy
  15. Altered cardiac repolarisation in highlanders with high‐altitude pulmonary hypertension during wakefulness and sleep
  16. Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters
  17. Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m
  18. Spirometry in Central Asian Lowlanders and Highlanders, a Population Based Study
  19. Effect of Breathing Oxygen-Enriched Air on Exercise Performance in Patients with Chronic Obstructive Pulmonary Disease: Randomized, Placebo-Controlled, Cross-Over Trial
  20. Right-to-left shunts in lowlanders with COPD traveling to altitude: a randomized controlled trial with dexamethasone
  21. Cognitive Effects of Repeated Acute Exposure to Very High Altitude Among Altitude-Experienced Workers at 5050 m
  22. Prevention of altitude-related illness in patients with COPD by acetazolamide. RCT
  23. Asthma rehabilitation at high vs. low altitude: randomized parallel-group trial
  24. Highlights from the 2018 European Respiratory Society International Congress: sleep and clinical physiology
  25. Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial
  26. Dexamethasone improves pulmonary hemodynamics in COPD-patients going to altitude: A randomized trial
  27. Blood pressure response to exposure to moderate altitude in patients with COPD
  28. Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters
  29. Sleep and breathing disturbances in patients with chronic obstructive pulmonary disease traveling to altitude: a randomized trial
  30. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension
  31. Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trial
  32. Efficacy of Dexamethasone in Preventing Acute Mountain Sickness in COPD Patients
  33. Right and Left Heart Function in Lowlanders with COPD at Altitude: Data from a Randomized Study
  34. Effects on Cognitive Functioning of Acute, Subacute and Repeated Exposures to High Altitude
  35. Postural Control in Lowlanders With COPD Traveling to 3100 m: Data From a Randomized Trial Evaluating the Effect of Preventive Dexamethasone Treatment
  36. Effect of Acute, Subacute, and Repeated Exposure to High Altitude (5050 m) on Psychomotor Vigilance
  37. Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
  38. The 2018 Lake Louise Acute Mountain Sickness Score
  39. Exercise Performance of Lowlanders with COPD at 2,590 m: Data from a Randomized Trial
  40. Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial
  41. Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial
  42. Mechanisms of Improved Exercise Performance under Hyperoxia
  43. Mechanisms of Improved Exercise Performance under Hyperoxia: On Haldane, Geppert, Zunz, and Eschenbacher Transformations
  44. Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders
  45. Dexamethasone reduces pulmonary artery pressure in lowlanders with COPD travelling to 3200m. A randomized, placebo-controlled trial: TABLE 1
  46. Cerebral oxygenation in lowlanders with COPD spending a night at 2590m:
  47. Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial:
  48. Physical activity in COPD and its relationship to exercise performance and sleep:
  49. Effect of hyperoxia on exercise performance in COPD: Randomized trial:
  50. Respiratory acclimatization and psychomotor performance during 3 weeks at 3200m:
  51. Postural control in COPD patients travelling from 760 m to 3200 m; randomized trial evaluating effects of dexamethasone
  52. Altitude related adverse health effects in lowlanders with COPD travelling to 3200m: Table 1
  53. Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m: TABLE
  54. Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of Acetazolamide
  55. Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension
  56. Disease-Targeted Treatment Improves Cognitive Function in Patients with Precapillary Pulmonary Hypertension
  57. Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m
  58. Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension
  59. Blood pressure response to altitude exposure in patients with COPD
  60. OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial
  61. Breathing and sleep disturbances in lowlanders with COPD travelling to 2590m
  62. Right and left ventricular function in lowlanders with COPD travelling to moderate altitude
  63. Risk of malignant arrhythmia in highlanders with high altitude pulmonary hypertension during wakefulness and sleep
  64. Time course of pulmonary artery pressure and clinical characteristics in Kyrgyz highlanders
  65. Cerebral oxygenation in highlanders with and without high-altitude pulmonary hypertension